GTR Home > Tests > Search results - C1866176[DISCUI]

Apply filters

Showing tests for all 1688 conditions

Compare labs

Your search term can be found in tests with a total of 1688 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1866176[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 21 tests for 1688 conditions in 10 labs

CLRP5

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)

CSkeletal Dysplasias NGS panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (371)
Total targets (161)

CFZD4. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CLRP5. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSkeletal Dysplasia: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (365)
Total targets (163)

COsteogenesis Imperfecta and Decreased Bone Density: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (81)
Total targets (34)

CVitreoretinopathy: Sequencing and Deletion/Duplication Panel

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (33)
Total targets (9)

CEye Disorders: Comprehensive Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (317)
Total targets (203)

CVitreoretinopathy and Wagner Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (29)
Total targets (6)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (752)
Total targets (392)

CExudative vitreoretinopathy 4

Lab: MedGene Bratislava, Bratislava, Slovakia
Test targets
Methods
  • C Sequence analysis of the entire coding region

CExudative vitreoretinopathy 4

Lab: Praxis fuer Humangenetik Wien Vienna, Wien, Austria
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTest for LRP5-Related Familial Exudative Vitreoretinopathy, Autosomal Recessive

Lab: Connective Tissue Gene Tests Allentown, PA, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

CTest for LRP5-Related Familial Exudative Vitreoretinopathy, Autosomal Dominant

Lab: Connective Tissue Gene Tests Allentown, PA, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

CTest for LRP5-Related Familial Exudative Vitreoretinopathy, Autosomal Dominant

Lab: CeGaT GmbH Tuebingen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

Showing 1 to 20 of 21 tests for 1688 conditions in 10 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk